Venture Life updates market on total voting rights

Venture Life ( (GB:VLG) ) has shared an announcement.

Venture Life Group has reported that as of 31 March 2026 it had 128,860,145 ordinary shares in issue, of which 7,032,072 are held in treasury, resulting in 121,828,073 voting rights. Each ordinary share carries one vote, and treasury shares carry no voting rights, establishing the denominator shareholders must use when assessing disclosure obligations under FCA transparency rules.

The clarification of total voting rights gives investors and regulatory authorities an updated reference point for monitoring significant shareholdings and changes in ownership. While the announcement is largely administrative, it underpins compliance with UK market disclosure standards and may inform institutional investors’ reporting and governance calculations.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on VLG Stock

According to Spark, TipRanks’ AI Analyst, VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on VLG stock, click here.

More about Venture Life

Venture Life Group is a UK-headquartered international consumer self-care company focused on the global self-care market. Its portfolio spans women’s intimate healthcare brand Balance Activ, ENT care product Earol, Lift and Glucogel for energy and glucose management, and Health & Her products supporting the hormonal lifecycle, sold via pharmacies, health & beauty chains, grocery multiples and e-commerce worldwide.

The group distributes directly to retailers in the UK, Ireland and the U.S., while relying on international distribution partners in other markets. Its products are typically recommended by pharmacists or healthcare practitioners, positioning the company in the higher-trust, over-the-counter self-care segment across multiple therapeutic niches.

Average Trading Volume: 298,920

Technical Sentiment Signal: Buy

Current Market Cap: £80.41M

See more data about VLG stock on TipRanks’ Stock Analysis page.